Biotech

Experimental Cancer Treatment That Terminates Rogue Cells Could Arrive in 2017

CAR T-cell therapy, a cutting-edge immunotherapy technique, is engineered to target cancer at a cellular level.

Published On 12/23/2016
2:01 PM EST